Please login to the form below
Dexcom
This page shows the latest Dexcom news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly set to launch Tempo Personalized Diabetes Management Platform
Moreover, the app is integrated with Dexcom Continuous Glucose Monitoring (CGM) Systems via secondary display, as well as the Tempo Blood Glucose Monitor (BGM) and other compatible BGMs.
Latest news
-
Dexcom launches next-generation continuous glucose monitor for diabetes patients
The launch follows news that the Dexcom ONE Real Time-CGM is now available for prescription on the NHS to all those with type 1 diabetes. ... We’re thrilled to begin the global rollout of Dexcom G7, our next-generation CGM technology, that vastly
-
NHS England to roll out continuous glucose monitors to all those with type 1 diabetes
The cost-effective deal with manufacturers DEXCOM will make the glucose monitors – that are traditionally more expensive than flash monitor counterparts – available on prescription via the NHS at a similar price. ... The monitor, Dexcom ONE Real
-
Novo Nordisk to launch connected insulin pens
Responding to this, Novo Nordisk has also signed new partnership agreements with leading players in digital diabetes tech: Dexcom, Glooko and Roche. ... Novo Nordisk will also integrate insulin-dosing data with Dexcom CGM data in the coming years.
-
VCCP Health lands record haul at the PM Society Awards
Target Award for Advertisement Campaign - Lime for Dexcom. Target Award for Primary Care Advertisement - vivacity for Mylan. ... Target Award for Secondary Care Advertisement - Lime for Dexcom. Best Use of Insight - VCCP Health for LEO Pharma.
-
Dexcom and Fitbit team up to tackle diabetes management
Will develop a wearable blood glucose tracking product. Continuous glucose monitoring (CGM) specialists DexCom and wearable brand company Fitbit will team up to develop a new blood glucose tracking product for ... The future Fitbit-Dexcom device will
More from news
Approximately 3 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
Insights from Cannes Lions Health Festival 2018
Case Study: No Needles. Agency: McCann Birmingham. Client: Dexcom. Award: Gold Lion.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Blog: Digital therapeutics: within our reach?
Dexcom G5 Mobile Continuous Glucose Monitoring System: a small sensor measures glucose levels just underneath the skin and transmits the reading to your mobile app using Bluetooth.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Pfizer reports positive results for elranatamab in multiple myeloma
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca to stop post-marketing study of Andexxa following early success
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- European Commission grants two new marketing authorisations for UCB's Bimzelx
- AstraZeneca/Sanofi’s RSV antibody backed by FDA advisory committee for infants
- Janssen shares positive phase 3 results for cilta-cel in multiple myeloma
- Parkinson’s disease: past, present and future
- How to Increase Engagement During Virtual Events
- AstraZeneca to stop post-marketing study of Andexxa following early success
No results were found
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Parkinson’s disease: past, present and future
- Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
